AstraZeneca Plc's (NASDAQ: AZN) subsidiary, Alexion, has agreed to acquire LogicBio Therapeutics Inc (NASDAQ: LOGC) for $2.07 per share. Both boards have unanimously approved the transaction.
Alexion plans to close the deal in four to six weeks, subject to the tender of at least a majority of the outstanding shares of LogicBio common stock.
It plans to retain LogicBio employees at their current location.
Also Read: LogicBio Therapeutics Shares Skyrocket As FDA Lifts Clinical Hold On Its Pediatric Trial.
The proposed acquisition brings LogicBio's unique technology, experienced rare disease R&D team, and expertise in pre-clinical development to support Alexion's growth in genomic medicines.
Fred Chereau, President and Chief Executive Officer, LogicBio, said, "Through this acquisition, we strive to accelerate our research in gene editing and AAV capsid development and together move the field of genomic medicine forward."
LogicBio has developed technology platforms for the delivery and insertion of genes to address genetic diseases and a platform designed to improve viral vector manufacturing processes.
Price Action: LOGC shares are up 633.9% at $2.00 during the premarket session on the last check Monday.
PhaseBio Might Have To Return Global Rights To Its Lead Program
Japan Approves AstraZeneca's Two Treatments For Asthma, Rare Form Of Cancer
Fox TV Host Shannon Bream Is Glad She Got Fired: 'I Watched My Tapes And Got Real With Myself' - Fox (NAS
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here. Since 2015, for the first time, the market witnessed two consecutive quarterly losses. During the second quarter, the S&P 500 Index continued its decline, trading at -16.1%. […]
Intel (NASDAQ: INTC) has been under tremendous pressure this year. Shares of the semiconductor company have tumbled about 50%. While Intel is facing its share of headwinds, I believe better days lie ahead for the tech giant and its big-time dividend.
Oil prices have bounced around quite a bit this year. Brent oil, the global-pricing benchmark, started 2022 below $80 a barrel before soaring into the $120s following Russia's invasion of Ukraine. With the prospect of higher oil prices, we asked some of our energy contributors what oil stocks they believe are best positioned to capitalize following OPEC's bold move.
Tax-loss harvesting has risen in popularity. BofA says the strategy could give a boost to underperforming stocks from November to January.
The veteran telecom company is having a stellar year in many respects, but reason for concern has emerged.
The three stocks that stood out to me are Taiwan Semiconductor (NYSE: TSM), Disney (NYSE: DIS), and Adobe (NASDAQ: ADBE). The company is a third-party manufacturer for chip leaders like Apple (NASDAQ: AAPL), Nvidia (NASDAQ: NVDA), and dozens of other companies designing their own chips.
You would think this would be TIPS’ time to shine. Instead, the prices of Treasury inflation-protected securities—government bonds that are adjusted to keep up with inflation—have declined this year, even as inflation has soared. The comparable loss for ICE’s index of regular Treasury bonds was 13.5%.
NIO Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $NIO performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.Check out the ticker page here.
PayPal is in trouble. "You are independently responsible for complying with all applicable laws in all of your actions related to your use of PayPal's services, regardless of the purpose of the use," the document, called "Acceptable Use of Policy," said.
This indicator has correctly predicted five steep stock market declines since 1870 -- and it's highly successful at calling bottoms, too!
For the retail investor, the only certainty of our current market environment is uncertainty. Volatility is up, and the main indexes are showing deepening losses. As if that wasn't enough, at least one market bull is turning a bit more pessimistic. JPMorgan strategist Marko Kolanovic has been one of the more bullish voices on Wall Street in recent months, but current conditions have him pushing the timeline back. While he still believes that the S&P 500 can hit 4,800, or a 32% gain from current
Luckily for everyday investors like us, institutions that trade stocks need to disclose their transactions to the Securities and Exchange Commission every three months. Ray Dalio's hedge fund, Bridgewater Associates, made a relatively large bet on CVS Health (NYSE: CVS) stock in the second quarter. It's CVS' less visible business segments that have allowed it to more than triple its dividend payout over the past decade.
The company's longtime CEO announced his retirement, leading some analysts to contemplate a cut to the 14% dividend.
The first quarter of 2022 has been difficult for retirement savers and retirees alike, and according to investment firm Charles Schwab, it was one of the worst quarters for fixed-income in decades. However, the rising yields and changed Federal Reserve … Continue reading → The post Charles Schwab Says Now Is the Time to Add This Asset to Your Retirement Portfolio appeared first on SmartAsset Blog.
High-yield dividend stocks can be powerful wealth-building tools. Three stocks that fit this definition today are Valero Energy (NYSE: VLO), Verizon Communications (NYSE: VZ), and Tanger Factory Outlet Centers (NYSE: SKT). Over the past decade, only a few oil and natural gas companies have beaten the S&P 500 on a total return basis.
Investing in Warren Buffett's biggest holdings can be a winning tactic, but don't overlook the companies that occupy smaller positions in Berkshire Hathaway's portfolio.
It may not be practical — at least for now.
The company is reaping benefits from investments in 5G technology, but that's not necessarily enough to make AT&T stock a buy.
Should I buy stocks now or wait? That's a question many investors are asking themselves right now.
Unless you borrow money to invest, the potential losses are limited. But if you pick the right stock, you can make a...